151 related articles for article (PubMed ID: 21684306)
1. Autoantibody detection with indirect immunofluorescence on HEp-2 cells: starting serum dilutions for systemic rheumatic diseases.
González DA; León AC; Varela AR; García MG; Rahola Mde S; Pérez Mdel C; Hernández AG; Falcón MJ; Díaz BB
Immunol Lett; 2011 Oct; 140(1-2):30-5. PubMed ID: 21684306
[TBL] [Abstract][Full Text] [Related]
2. Detection of antinuclear antibodies: comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods.
Homburger HA; Cahen YD; Griffiths J; Jacob GL
Arch Pathol Lab Med; 1998 Nov; 122(11):993-9. PubMed ID: 9822128
[TBL] [Abstract][Full Text] [Related]
3. Efficiency of different strategies to detect autoantibodies to extractable nuclear antigens.
Almeida González D; Cabrera de León A; Rodríguez Pérez Mdel C; Brito Díaz B; González Hernández A; García García D; Vázquez Moncholi C; Aguirre Jaime A
J Immunol Methods; 2010 Aug; 360(1-2):89-95. PubMed ID: 20600078
[TBL] [Abstract][Full Text] [Related]
4. Utility of age, gender, ANA titer and pattern as predictors of anti-ENA and -dsDNA antibodies.
Kang I; Siperstein R; Quan T; Breitenstein ML
Clin Rheumatol; 2004 Dec; 23(6):509-15. PubMed ID: 15801070
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of the methods used for the detection of antinuclear antibodies].
Berkem R; Gümüş T; Karakoç E; Acar N
Mikrobiyol Bul; 2003; 37(2-3):171-8. PubMed ID: 14593900
[TBL] [Abstract][Full Text] [Related]
6. Cost-effective detection of non-antidouble-stranded DNA antinuclear antibody specificities in daily clinical practice.
Vos PA; Bast EJ; Derksen RH
Rheumatology (Oxford); 2006 May; 45(5):629-35. PubMed ID: 16368728
[TBL] [Abstract][Full Text] [Related]
7. Detection and identification of significant ANAs in previously determined ANA negative samples.
Kidd K; Cusi K; Mueller R; Goodner M; Boyes B; Hoy E
Clin Lab; 2005; 51(9-10):517-21. PubMed ID: 16285474
[TBL] [Abstract][Full Text] [Related]
8. Italian multicentre study for application of a diagnostic algorithm in autoantibody testing for autoimmune rheumatic disease: conclusive results.
Bonaguri C; Melegari A; Ballabio A; Parmeggiani M; Russo A; Battistelli L; Aloe R; Trenti T; Lippi G
Autoimmun Rev; 2011 Nov; 11(1):1-5. PubMed ID: 21741498
[TBL] [Abstract][Full Text] [Related]
9. Determination of Specificity and Pattern of Antinuclear Antibodies (ANA) in Systemic Rheumatic Disease Patients Positive for ANA Testing.
Tipu HN; Bashir MM
J Coll Physicians Surg Pak; 2018 Jan; 28(1):40-43. PubMed ID: 29290190
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of indirect immunofluorescence assay and ELISA for detecting antinuclear antibodies and anti-double-stranded DNA antibodies].
Qin X; Tao X; Chen ZJ; Jiang JQ; Xu MH; Li RL; Li TJ; Lin FQ; Li S
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):472-5. PubMed ID: 19304528
[TBL] [Abstract][Full Text] [Related]
11. Testing for antibodies to ENA and to dsDNA is not indicated in FANA-negative sera.
Manoussakis MN; Garalea KL; Tzioufas AG; Moutsopoulos HM
Clin Rheumatol; 1988 Dec; 7(4):465-9. PubMed ID: 3073034
[TBL] [Abstract][Full Text] [Related]
12. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the BioPlex 2200 ANA screen for the detection of antinuclear antibodies and comparison with conventional methods.
Desplat-Jego S; Bardin N; Larida B; Sanmarco M
Ann N Y Acad Sci; 2007 Aug; 1109():245-55. PubMed ID: 17785313
[TBL] [Abstract][Full Text] [Related]
14. Detection and identification of antinuclear antibodies (ANA) in a large community hospital.
Verstegen G; Duyck MC; Meeus P; Ravelingien I; De Vlam K
Acta Clin Belg; 2009; 64(4):317-23. PubMed ID: 19810418
[TBL] [Abstract][Full Text] [Related]
15. An italian multicenter study for application of a diagnostic algorithm in autoantibody testing.
Bonaguri C; Melegari A; Dall'Aglio P; Ballabio A; Terenziani P; Russo A; Battistelli L; Aloe R; Camisa R; Campaniello G; Sartori E; Monica C
Ann N Y Acad Sci; 2009 Sep; 1173():124-9. PubMed ID: 19758140
[TBL] [Abstract][Full Text] [Related]
16. Correlation of antinuclear antibody immunofluorescence patterns with immune profile using line immunoassay in the Indian scenario.
Sebastian W; Roy A; Kini U; Mullick S
Indian J Pathol Microbiol; 2010; 53(3):427-32. PubMed ID: 20699497
[TBL] [Abstract][Full Text] [Related]
17. Multiplex assessment of non-organ-specific autoantibodies with a novel microbead-based immunoassay.
Grossmann K; Roggenbuck D; Schröder C; Conrad K; Schierack P; Sack U
Cytometry A; 2011 Feb; 79(2):118-25. PubMed ID: 21265005
[TBL] [Abstract][Full Text] [Related]
18. Detection of anti-nuclear antibodies by indirect immunofluorescence on HEp-2 cells: setting the appropriate screening dilution for the diagnosis of autoimmune rheumatic diseases.
Brito Fde A; Santos SM; Ferreira GA; Pedrosa W; Gradisse J; Costa LC; Neves SP
Rev Bras Reumatol; 2014; 54(1):13-20. PubMed ID: 24878786
[TBL] [Abstract][Full Text] [Related]
19. Laboratory screening of connective tissue diseases by a new automated ENA screening assay (EliA Symphony) in clinically defined patients.
González C; García-Berrocal B; Pérez M; Navajo JA; Herraez O; González-Buitrago JM
Clin Chim Acta; 2005 Sep; 359(1-2):109-14. PubMed ID: 15894301
[TBL] [Abstract][Full Text] [Related]
20. Can an ELISA replace immunofluorescence for the detection of anti-nuclear antibodies?--The routine use of anti-nuclear antibody screening ELISAs.
Sinclair D; Saas M; Williams D; Hart M; Goswami R
Clin Lab; 2007; 53(3-4):183-91. PubMed ID: 17447656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
